Sign inJoin waitlistJoin the waitlist

FM

Fady Malik

Executive Vice President of Research & Development, Cytokinetics · Stanford Health Care

Credentials: · · ·

History

Stanford Health Care
Present

University of California-San Francisco
2000–2001
Cardiovascular Disease
University of California-San Francisco
1996–2000
Internal Medicine
University of California-San Francisco
1994–1996
University of California, San Francisco School of Medicine
1990–1994

Research

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
New England Journal of Medicine · 2021 · 487 citations
Cardiac myosin activation: a potential therapeutic approach for systolic heart failure
Science · 2011 · First of 34 authors · Corresponding · 484 citations
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2…
The Lancet · 2011 · Last of 21 authors · 271 citations

SK
Stuart Kupfer
59 papers
SH
Stephen Heitner
52 papers
SS
Scott Solomon
51 papers
DJ
Daniel Jacoby
33 papers
John Teerlink
33 papers
Martin Maron
32 papers
Ahmad Masri
31 papers
Gary Felker
27 papers
Michael Nassif
23 papers
Anjali Owens
21 papers
Gregory Lewis
18 papers
Theodore Abraham
18 papers